Literature DB >> 3576854

Pharmacologic treatment of uric acid calculi.

G M Preminger.   

Abstract

Uric acid stone disease is dependent on three pathogenetic factors: acid urine pH, low urine volume, and hyperuricosuria. The management of nonobstructing uric acid calculi should include maintenance of an alkaline urine, an increase in urine volume, and reduction in urinary uric acid excretion. It appears that potassium alkali may avoid the complication of calcium stone formation in patients with uric acid stones. In patients with obstructing uric acid calculi, more rapid dissolution may be accomplished with intravenous alkalinization or direct irrigation of the stone with an alkaline solution.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3576854

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  7 in total

Review 1.  [Evidence-based pharmacological metaphylaxis of stone disease].

Authors:  M Straub; R E Hautmann
Journal:  Urologe A       Date:  2006-11       Impact factor: 0.639

Review 2.  Prophylaxis of uric acid and cystine stones.

Authors:  B Hess
Journal:  Urol Res       Date:  1990

Review 3.  Metabolic syndrome and the genesis of uric acid stones.

Authors:  Naim M Maalouf
Journal:  J Ren Nutr       Date:  2011-01       Impact factor: 3.655

Review 4.  Diagnosis and metaphylaxis of stone disease. Consensus concept of the National Working Committee on Stone Disease for the upcoming German Urolithiasis Guideline.

Authors:  M Straub; W L Strohmaier; W Berg; B Beck; B Hoppe; N Laube; S Lahme; M Schmidt; A Hesse; K U Koehrmann
Journal:  World J Urol       Date:  2005-11-29       Impact factor: 4.226

Review 5.  Urolithiasis in children: current medical management.

Authors:  J Laufer; H Boichis
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

6.  Uric Acid nephrolithiasis: recent progress and future directions.

Authors:  Tin C Ngo; Dean G Assimos
Journal:  Rev Urol       Date:  2007

Review 7.  Epidemiology, pathophysiology, and management of uric acid urolithiasis: A narrative review.

Authors:  A Abou-Elela
Journal:  J Adv Res       Date:  2017-04-28       Impact factor: 10.479

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.